This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Tutor Perini Joint Venture Prevails In Court Decision Regarding The Central Artery Project

Tutor Perini Corporation (NYSE: TPC), a leading civil and building construction company, today announced that its Perini-Kiewit-Cashman (PKC) Joint Venture recently prevailed in a court decision in its long-standing dispute with the Massachusetts Department of Transportation (MassDOT) regarding the Central Artery/Tunnel Project in Boston. Tutor Perini is the managing partner in the joint venture with a 56% interest.

The dispute is related to a series of claims for additional contract time and compensation against MassDOT for work performed by PKC on a portion of the Central Artery/Tunnel Project. During construction, MassDOT ordered PKC to perform changes to the work and issued related direct cost changes, excluding time delay and inefficiency costs. A three-member Dispute Resolution Board (DRB) issued several awards and interim decisions in favor of PKC’s claims. MassDOT had sought and was successful in having the DRB’s binding awards vacated under the premise that the DRB exceeded its authority.

The decision this week, issued by Superior Court Justice Thomas P. Billings, affirmed the DRB’s role as the binding arbitrator. In issuing its decision, the court ruled that each of the claims at issue for the Third and Fourth DRB panels are, in fact, subject to the binding dispute resolution process, and the DRB’s awards on these claims are reinstated.

Commenting on the decision, Tutor Perini’s CEO, Ronald N. Tutor, said, “The Joint Venture is extremely pleased with the judge’s decision on the C11 case involving the Central Artery that has been ongoing in excess of 15 years. The Dispute Review Boards’ decisions and awards, including accrued interest to date, exceed $80,000,000 as the amount due currently to our Joint Venture. This still leaves substantial additional non-binding DRB awards to be either adjudicated or resolved between the parties. This decision certainly vindicates our position and the vigor with which we pursued this litigation over all these years.”

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,757.91 +138.40 0.79%
S&P 500 2,077.42 +14.31 0.69%
NASDAQ 5,013.1230 +26.2560 0.53%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs